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Response to Comment on ‘‘Screening for Abdominal
Aortic Aneurysm and Overall Mortality in Men’’
Dr. Koelemay must be acknowledged for his careful review
of the meta-analysis, which has revealed a citation error in
the manuscript, for which we apologise. The data used in
the original and revised long-term meta-analyses are not
from the preliminary 10-year report from the Viborg study
as cited,1 but from the complete 7-year report,2 as for the
MASS trial.3 If the preliminary 10-year results are used in
the long-term analysis, we agree that the upper 95% C.I.
limit for the odds ratio hits 1.00.
For interpretation, one has to remember the effect of
screening and the data used in the calculation of odds
ratios. The effect is a delay of death but in the end, we are
all going to die. Thus, the most relevant statistics to use are
survival analyses. However, this would require merging of
results from all the randomised trials. This has been
attempted but without success. Consequently, we can only
use meta-analysis to address this question. However,
calculation of the pooled odds ratio is based upon the
number of deaths in the invited group versus the control
group and ultimately the numbers will be equal in the two
groups, and the OR will become 1.00. The modified calcu-
lation seems just to be a manifestation of that progression.
The existing meta-analysis still shows that screening
reduces overall mortality, and the risk association would
probably have been even stronger if seven-year results
from the Chichester and Australian Studies had been
available instead of after 15 and 12 years, respectively.References
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Sir,
We were surprised by the publication of this systematic
review. However valuable, the topic and contents are the
sameaswas publishedearlier in the British Journal of Surgery
and the Cochrane Library.1,2 Publication of a Cochrane
systematic review also in a paper-based medical journal has
been accepted to enlarge the readership to those who have
limited access to the Cochrane Library.
Theauthorsof thepresentpaper includevirtually thesame
trials and reach a similar conclusion. They even refer to the
previous systematic review, but do not (and obviously cannot)
indicate what is new in their work. Although this may be
deductable to a juxtaposition of nearly simultaneous publi-
cations, it has led to redundancy in the surgical literature.
Although we understand the interest of editors of
medical journals to include systematic reviews as poten-
tially high-referenced sources of the state-of-the-art for
their readers, they should avoid even the semblance of
double publication. For this purpose, a section with
summaries of interesting work published in other journals
would be fair to the original authors. The Journal of
Vascular Surgery has done so, but without referring to the
original authors.3 Again, such a publication appears neither
original nor ethical.
In preparing their manuscript, authors should definewhat
is known and motivate what is new in what they want toDOI of original article: 10.1016/j.ejvs.2008.06.010.
Correspondence 741publish in order to avoid redundancy. Manuscript reviewers
should also be vigilant about this. In 2006 Dr. Murie, Editor-
in-Chief of the British Journal of Surgery, addressed a similar
dilemma before,4 to emphasize the responsibilities of
authors, reviewers, and editors regarding this matter.References
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Response to Letter to the Editor
Sir,
Ubbink et al. have published a systematic review on nega-
tive pressure wound therapy in the British Journal of
Surgery in the beginning of 2008 along with a double
publication in the Cochrane Library. They consider that our
paper later in 2008 in the European Journal of Vascular
Surgery poses a double publication of their work as the
original trials are very much the same.
We consider the points raised by Ubbink et al. unjus-
tified, unscientific and unethical. Objectivity and repeat-
ability of the findings is a fundamental principle in science
and this principle encompasses both original studies and
systematic reviews. We found ten previous systematic
reviews published on negative pressure wound therapy,DOI of original article: 10.1016/j.ejvs.2009.01.018.the review by Ubbink et al. being one of those reviews.
We have referred to these publications in our paper. The
need for new reviews is based not only on repeatability
of findings but on different study questions in the
previous reviews and in other differences in the review
protocols.
The suggestion of a double publication is entirely
groundless. We did plan our study protocol already in 2006
and our data for the meta-analysis was collected by an
informatician at the Finnish Office for Health Technology
Assessment in July 2006 and the search was revisited in
January 2008 as stated in our materials and methods. Our
first submission to EJVES was dated in March 31st, 2008 and
our final revision was submitted in June 3rd, 2008. Thus our
paper was entirely independent of the work by Ubbink
et al. We find it extraordinary that Ubbink et al. consider
that we should not have had the right to publish our paper.
We think that this is unjustified and violates the principles
of scientific publication.1
Redundant or duplicate publication is considered when
the same data is used to generate several publications and
most often when the same author or group reports their
data in different papers. Ubbink et al. refer to an editorial
by Murie et al., in which a case of redundant publication on
a series of laparoscopic cholecystectomy complications is
discussed. In this case the two original publications
included overlapping cases and the authors discussed this
being due to changes during the peer-review process. This
discussion should not be confused with the current one
where there were two entirely separate scientific
publications.
The efficacy, effectiveness and safety of negative pres-
sure wound therapy is and continues to be of high relevance
as the technology diffuses rapidly into the health care
without sufficient evidence of its effectiveness, but a high
level of economical interests. Further trials have been and
will be published on negative pressure wound therapy in
the coming years and we hope that the body of evidence
will grow.
We look forward to new systematic reviews on this
important topic.Reference
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